Bruce Slovin
CIK 1248295 · last filed 2017-05-19
Bruce Slovin is a corporate insider who has filed 104 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing, for SIGA, was dated May 19, 2017. Across all open-market trades the lifetime net is −$2.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $738.8K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
CMN price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
NEW YORK, NY 10021
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SIGA | Director | 234,167 | $3.15 | $738.8K | $723.7K | 19 | 2017-05-19 |
| CANTEL MEDICAL CORP (CMN) Delisted | Director | 214,377 | — | — | -$2.79M | 72 | 2016-08-02 |
Recent Filings
104 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-05-19 | SIGA | Exer (M) | +15,000 | $0 | EDGAR |
| 2016-11-18 | SIGA | Exer (M) | +54,167 | $4.40B | EDGAR |
| 2016-08-02 | CANTEL MEDICAL CORP (CMN) Delisted | Mixed | +747 | $0 | EDGAR |
| 2016-05-17 | SIGA | Mixed | +15,000 | $0 | EDGAR |
| 2015-08-04 | CANTEL MEDICAL CORP (CMN) Delisted | Grant (A) | +927 | $0 | EDGAR |
| 2015-07-27 | CANTEL MEDICAL CORP (CMN) Delisted | Exer (M) | +10,125 | $71.4K | EDGAR |
| 2015-06-12 | CANTEL MEDICAL CORP (CMN) Delisted | Mixed | −58,877 | $0 | EDGAR |
| 2015-05-18 | SIGA | Mixed | +15,000 | $0 | EDGAR |
| 2014-12-12 | CANTEL MEDICAL CORP (CMN) Delisted | Gift (G) | −32,125 | $0 | EDGAR |
| 2014-10-20 | CANTEL MEDICAL CORP (CMN) Delisted | Exer (M) | +1,688 | $12.0K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.